
Notable Labs
Personalized drug discovery for blood cancer.
- Founded
- 2014
- Status
- Public
- Stage
- Growth
- Team size
- 40
- Location
- San Francisco, CA, USA; Foster City
- Category
- Biotech & Drug Discovery
- Sector
- Diagnostics
About Notable Labs
Notable Labs is building a personalized drug discovery platform to identify treatment options for relapsed and refractory cancer patients — starting with blood cancer — to address the long tail of cancer treatment. We look at a person’s actual cancer cells, test combinations of FDA approved drugs, and see which combinations kill the cancer cells and leave the healthy cells alive. We focus on combinations because cancer is often difficult to target with just one drug and starting with a single drug can lead to resistant clones or relapse. We're building a highly automated lab in Foster City running on our custom software and are currently testing relapsed/refractory cancer patients as well as samples from a variety of pharma/biotech partnerships. https://www.notablelabs.com/careers
Clinical trials
1 registered trial with this company as lead sponsor, 2019.
- Status
- Completed (1)
- Conditions
- Acute Myelogenous Leukemia, Multiple Myeloma, Myelodysplastic Syndromes, Lymphoma, Acute Lymphoblastic Leukemia
Source: ClinicalTrials.gov.
Securities filings
6 Form D filings on record, 2016 to 2023.
Filed as Notable Labs, Inc.
Source: SEC EDGAR. Form D reports an exempt offering; it does not confirm funds raised.
Company data compiled and maintained by Healthcare Discovery.
